Just noticed Cognition Therapeutics' CEO Lisa Ricciardi actually bought 38k shares of her own company stock recently for like $30k. That's always a good sign when leadership puts their own money in, right? Anyway, she was presenting at some investor conference last year about their Alzheimer's drug zervimesine showing positive Phase 2 results. Interesting thing is institutional investors have been all over the place with this one - some adding heavy positions, others bailing completely. Lisa Ricciardi seems bullish on their 2025 plans though. Not sure if it's just me but when CEOs are buying their own stock while presenting good data, that usually means something. You guys tracking biotech plays or nah?